IE
BLCM

Israel Englander’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Israel Englander’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,595
Closed -$16K – 7191
2022
Q4 		$16K Buy
+21,595
New +$21.4K ﹤0.01% 6099
2021
Q1 		– Sell
-16,248
Closed -$57K – 6648
2020
Q4 		$57K Buy
+16,248
New +$68.6K ﹤0.01% 5078
2020
Q2 		– Sell
-16,521
Closed -$77K – 4748
2020
Q1 		$77K Buy
+16,521
New +$177K ﹤0.01% 3606
2019
Q4 		– Sell
-4,333
Closed -$45K – 4756
2019
Q3 		$45K Sell
4,333
-6,704
-61% -$87.6K ﹤0.01% 4054
2019
Q2 		$188K Buy
11,037
+1,435
+15% +$38.8K ﹤0.01% 3773
2019
Q1 		$324K Sell
9,602
-27,935
-74% -$934K ﹤0.01% 3508
2018
Q4 		$1.1M Sell
37,537
-23,079
-38% -$1.02M ﹤0.01% 2537
2018
Q3 		$3.73M Sell
60,616
-12,769
-17% -$864K ﹤0.01% 2015
2018
Q2 		$5.42M Buy
73,385
+48,798
+198% +$3.8M 0.01% 1764
2018
Q1 		$1.61M Buy
24,587
+12,161
+98% +$918K ﹤0.01% 2439
2017
Q4 		$1.04M Buy
+12,426
New +$1.22M ﹤0.01% 2678
2017
Q3 		– Sell
-12,784
Closed -$1.49M – 3975
2017
Q2 		$1.49M Buy
12,784
+1,283
+11% +$159K ﹤0.01% 2243
2017
Q1 		$1.42M Buy
11,501
+7,238
+170% +$948K ﹤0.01% 2199
2016
Q4 		$581K Buy
+4,263
New +$757K ﹤0.01% 2612
2016
Q2 		– Sell
-27,598
Closed -$2.58M – 3708
2016
Q1 		$2.58M Sell
27,598
-15,321
-36% -$1.67M 0.01% 1645
2015
Q4 		$8.7M Sell
42,919
-56,343
-57% -$10.1M 0.02% 1002
2015
Q3 		$14.4M Buy
99,262
+46,604
+89% +$8.55M 0.03% 726
2015
Q2 		$11.2M Buy
52,658
+26,672
+103% +$6.54M 0.02% 908
2015
Q1 		$6.02M Buy
25,986
+15,270
+142% +$3.69M 0.01% 1311
2014
Q4 		$2.47M Buy
+10,716
New +$2.3M 0.01% 1843

Other funds holding BLCM

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Israel Englander's BLCM Position: Q1 2023 in Review

Israel Englander sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2023, closing a stake of 21,595 shares — an estimated $16K sold.

Israel Englander first reported a position in BLCM in Q4 2014 and held it in 20 quarters. The position peaked at $14.4M in Q3 2015. 25 funds tracked by Wall St. Rank hold BLCM as of Q1 2023.

  • Israel Englander reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Israel Englander sold 21,595 Bellicum Pharmaceuticals, Inc. shares in Q1 2023, an estimated $16K.
  • Israel Englander first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 20 quarters.
  • Israel Englander's Bellicum Pharmaceuticals, Inc. position peaked at $14.4M in Q3 2015.
  • 25 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.